Table of Contents

Articles

• Open Access

  Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors

  TOMOYUKI ISHIGURO, KAZUYUKI TAKEDA, DAISUKE TAKAYANAGI, EMIKO MURA, RISAKO SUZUKI, TOSHIAKI TSURUI, NANA IRIGUCHI, YUYA HIRASAWA, RYOTARO OHKUMA, MASAHIRO SHIMOKAWA, HIROTSUGU ARIIZUMI, YUTARO KUBOTA, ATSUSHI HORIIKE, MASAHIKO IZUMIZAKI, SATOSHI WADA, KIYOSHI YOSHIMURA, ROBERT M. HOFFMAN and TAKUYA TSUNODA

  Cancer Genomics & Proteomics January 2025, 22 (1) 1-12; DOI: https://doi.org/10.21873/cgp.20481
• Open Access

  G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of SERPINE1/PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells In Vitro

  LINEA RÖRIG, SOPHIA RUCKRIEGL, JULIA GALLWAS and CARSTEN GRÜNDKER

  Cancer Genomics & Proteomics January 2025, 22 (1) 13-23; DOI: https://doi.org/10.21873/cgp.20482
• Open Access

  Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOM Rearrangement, SF3B1 Mutation, and Transient TNIP1::PDGFRB Chimera

  KRISTIN ANDERSEN, GEIR E. TJØNNFJORD, MALU LIAN HESTDALEN, SIGNE SPETALEN and IOANNIS PANAGOPOULOS

  Cancer Genomics & Proteomics January 2025, 22 (1) 24-33; DOI: https://doi.org/10.21873/cgp.20483
• Open Access

  Whole-genome Sequencing Analysis of Bile Tract Cancer Reveals Mutation Characteristics and Potential Biomarkers

  TOSHIO KOKURYO, MASAKI SUNAGAWA, JUNPEI YAMAGUCHI, TAISUKE BABA, SHOJI KAWAKATSU, NOBUYUKI WATANABE, SHUNSUKE ONOE, TAKASHI MIZUNO and TOMOKI EBATA

  Cancer Genomics & Proteomics January 2025, 22 (1) 34-40; DOI: https://doi.org/10.21873/cgp.20484
• Open Access

  Two Different NF1 Pathogenic Variants in a Family With Neurofibromatosis Type 1

  TABEA I. HARTUNG, LAN KLUWE, REINHARD E. FRIEDRICH and SAID C. FARSCHTSCHI

  Cancer Genomics & Proteomics January 2025, 22 (1) 41-45; DOI: https://doi.org/10.21873/cgp.20485
• Open Access

  Contribution of Cyclin Dependent Kinase Inhibitor 1A Genotypes to Childhood Acute Lymphocytic Leukemia Risk in Taiwan

  CHAO-CHUN CHEN, CHUNG-LIN TSAI, JEN-SHENG PEI, HUEY-EN TZENG, PEI-CHEN HSU, DA-CHUAN CHENG, JIUNN-CHERNG LIN, CHIA-WEN TSAI, DA-TIAN BAU and WEN-SHIN CHANG

  Cancer Genomics & Proteomics January 2025, 22 (1) 46-54; DOI: https://doi.org/10.21873/cgp.20486
• Open Access

  FAM32A Suppression Decreases 5-Fluorouracil-induced Apoptosis and Is Associated With Poor Prognosis in Gastric Cancer

  YUYA AGATSUMA, DAI SHIMIZU, SHINICHI UMEDA, HARUYOSHI TANAKA, NORIFUMI HATTORI, MASAMICHI HAYASHI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA, MICHITAKA FUJIWARA and YASUHIRO KODERA

  Cancer Genomics & Proteomics January 2025, 22 (1) 55-69; DOI: https://doi.org/10.21873/cgp.20487
• Open Access

  FN1 and VEGFA Are Potential Therapeutic Targets in Glioblastoma as Determined by Bioinformatics Analysis

  MIJUNG IM, JUNGWOOK ROH, WONYI JANG and WANYEON KIM

  Cancer Genomics & Proteomics January 2025, 22 (1) 70-80; DOI: https://doi.org/10.21873/cgp.20488
• Open Access

  Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma

  SUPAKAN AMONTAILAK, ATTAPOL TITAPUN, APINYA JUSAKUL, RAYNOO THANAN, PHONGSARAN KIMAWAHA, WASSANA JAMNONGKAN, MALINEE THANEE, PAPITCHAYA SIRITHAWAT, SONGPOL HAOHAN and ANCHALEE TECHASEN

  Cancer Genomics & Proteomics January 2025, 22 (1) 81-89; DOI: https://doi.org/10.21873/cgp.20489
• Open Access

  Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells

  NANKE MURRA, NINA SOPHIE POMMERT, BERIT SCHMIDT, REEMA SAMI ISSA, MEIKE KAEHLER, HENRIKE BRUCKMUELLER, VERA TIM, INGOLF CASCORBI and VICKI WAETZIG

  Cancer Genomics & Proteomics January 2025, 22 (1) 90-102; DOI: https://doi.org/10.21873/cgp.20490
• Open Access

  Immunohistochemical Analysis of a1-Acid Glycoprotein and Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma

  AYANO EZAKI, HIROMU YANO, CHENG PAN, YUKIO FUJIWARA, TOSHIKI ANAMI, YUKI IBE, YOUJIRO OZAKI, HIDEKAZU NISHIZAWA, TAKANOBU MOTOSHIMA, JUNJI YATSUDA, HIROSHI WATANABE, TORU MARUYAMA, TORU TAKEO, TOMOMI KAMBA and YOSHIHIRO KOMOHARA

  Cancer Genomics & Proteomics January 2025, 22 (1) 103-111; DOI: https://doi.org/10.21873/cgp.20491
• Open Access

  KRAS Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and KRAS G12/G13 Detection in Cell-Free DNA

  PITCHASAK THONGYOO, JARIN CHINDAPRASIRT, CHAIWAT APHIVATANASIRI, PIYAPHAROM INTARAWICHIAN, WARITTA KUNPROM, SARINYA KONGPETCH, ANCHALEE TECHASEN, WATCHARIN LOILOME, NISANA NAMWAT, ATTAPOL TITAPUN and APINYA JUSAKUL

  Cancer Genomics & Proteomics January 2025, 22 (1) 112-126; DOI: https://doi.org/10.21873/cgp.20492
• Open Access

  RFC3 Knockdown Decreases Cervical Cancer Cell Proliferation, Migration and Invasion

  JAE WOONG KOH and SEON-JOO PARK

  Cancer Genomics & Proteomics January 2025, 22 (1) 127-135; DOI: https://doi.org/10.21873/cgp.20493